In non-small-cell lung cancer, NLRC5 seems to be a negative indicator of prognosis (63), whereas in other types such as endometrial cancer and melanoma, NLRC5 downregulation has been correlated with poor prognosis (20, 64, 65). Here, NLRC5 is linked to melanoma.